Key insights
- Morgan Stanley slightly lowered its price target for Equifax (EFX) from $244 to $243 despite a Q1 earnings beat. While Q1 was strong due to mortgage performance, Equifax maintained its 2026 guidance, citing geopolitical uncertainty and rate increases. Flat growth is expected in the Government segment for Q2. The slight price target reduction and cautious outlook suggest a mildly bearish signal for EFX and potentially the broader financial sector.
Investing.com - Morgan Stanley lowered its price target on Equifax Inc. (NYSE:EFX) to $243 from $244 while maintaining an Overweight rating on the stock.
The firm said Equifax reported a solid first-quarter performance, beating Morgan Stanley estimates on revenue, adjusted EBITDA, and adjusted EPS by 3%, 5%, and 14% respectively. Organic revenue growth in the quarter reached 13%, compared to Morgan Stanley’s prior estimate of 9.6% and consensus of 12.2%.
The company maintained its underlying guidance for 2026 despite the first-quarter beat, citing increased geopolitical uncertainty, rate increases, and recent sluggish mortgage volumes. Equifax raised its headline guidance due to foreign exchange tailwinds.
Morgan Stanley noted the first-quarter beat was primarily driven by mortgage performance. The firm said Equifax expects flat growth in the Government segment for the second quarter, below expectations, due to a difficult comparison from the prior year’s Social Security Administration contract win and timing of state contract activations.
Following the results, Morgan Stanley lowered its 2026 adjusted EBITDA estimate for Equifax by 1%. The firm reduced its DCF-based price target to $243 from $244.For investors seeking deeper insights into Equifax’s valuation and growth prospects, the company is among the 1,400+ US equities covered by comprehensive InvestingPro Pro Research Reports, which transform complex Wall Street data into clear, actionable intelligence through intuitive visuals and expert analysis.
In other recent news, Equifax Inc. reported stronger-than-expected financial results for the first quarter of 2026. The company’s earnings per share came in at $1.86, surpassing analysts’ expectations of $1.70. Additionally, Equifax’s revenue exceeded projections, reaching $1.649 billion compared to the anticipated $1.62 billion. Despite these positive earnings and revenue results, the stock experienced a decline in pre-market trading, indicating potential investor caution in the face of broader market uncertainties. These developments highlight the company’s financial performance amidst a challenging economic environment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.